Quanterix Corporation (QTRX)
USD 6.21
(-7.59%)
USD 6.21
(-7.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 70.64 Million USD | 50.14% |
| 2022 | 46.23 Million USD | -25.1% |
| 2021 | 61.72 Million USD | 28.11% |
| 2020 | 48.18 Million USD | 79.54% |
| 2019 | 26.83 Million USD | 49.22% |
| 2018 | 17.98 Million USD | 80.07% |
| 2017 | 9.98 Million USD | 28.9% |
| 2016 | 7.74 Million USD | 35.57% |
| 2015 | 5.71 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 20.05 Million USD | 2.2% |
| 2024 Q1 | 19.62 Million USD | 49.97% |
| 2023 Q1 | 16.7 Million USD | 34.94% |
| 2023 Q2 | 18.98 Million USD | 13.64% |
| 2023 FY | 69.41 Million USD | 50.14% |
| 2023 Q3 | 17.28 Million USD | -8.95% |
| 2023 Q4 | 13.08 Million USD | -24.28% |
| 2022 Q2 | 8.63 Million USD | -40.68% |
| 2022 Q3 | 10.66 Million USD | 23.46% |
| 2022 FY | 46.23 Million USD | -25.1% |
| 2022 Q1 | 14.55 Million USD | -10.47% |
| 2022 Q4 | 12.37 Million USD | 16.1% |
| 2021 Q4 | 16.26 Million USD | 14.23% |
| 2021 Q1 | 14.05 Million USD | -6.59% |
| 2021 Q2 | 12.93 Million USD | -8.01% |
| 2021 FY | 61.72 Million USD | 28.11% |
| 2021 Q3 | 14.23 Million USD | 10.08% |
| 2020 Q4 | 15.05 Million USD | -21.52% |
| 2020 FY | 48.18 Million USD | 79.54% |
| 2020 Q3 | 19.17 Million USD | 267.87% |
| 2020 Q2 | 5.21 Million USD | -23.48% |
| 2020 Q1 | 6.81 Million USD | -0.76% |
| 2019 FY | 26.83 Million USD | 49.22% |
| 2019 Q3 | 7.03 Million USD | 1.47% |
| 2019 Q2 | 6.93 Million USD | 15.38% |
| 2019 Q4 | 6.86 Million USD | -2.39% |
| 2019 Q1 | 6 Million USD | 14.55% |
| 2018 Q3 | 5.59 Million USD | 40.83% |
| 2018 Q4 | 5.24 Million USD | -6.27% |
| 2018 FY | 17.98 Million USD | 80.07% |
| 2018 Q1 | 665 Thousand USD | -76.92% |
| 2018 Q2 | 3.97 Million USD | 497.44% |
| 2017 Q4 | 2.88 Million USD | 12.32% |
| 2017 Q1 | 2.36 Million USD | -34.23% |
| 2017 Q2 | 2.18 Million USD | -7.58% |
| 2017 FY | 9.98 Million USD | 28.9% |
| 2017 Q3 | 2.56 Million USD | 17.61% |
| 2016 Q3 | 1.32 Million USD | 24.58% |
| 2016 Q2 | 1.06 Million USD | -40.17% |
| 2016 Q1 | 1.77 Million USD | 0.0% |
| 2016 FY | 7.74 Million USD | 35.57% |
| 2016 Q4 | 3.58 Million USD | 171.2% |
| 2015 FY | 5.71 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 2352.024% |
| Cerus Corporation | 86.4 Million USD | 18.234% |
| OrthoPediatrics Corp. | 111.25 Million USD | 36.5% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -9452.876% |
| Talis Biomedical Corporation | 371 Thousand USD | -18942.049% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -754.141% |
| Inogen, Inc. | 126.69 Million USD | 44.241% |
| Spectral AI, Inc. | 7.88 Million USD | -796.523% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 1171.693% |
| CVRx, Inc. | 33.03 Million USD | -113.826% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -115713.115% |
| Orthofix Medical Inc. | 486.27 Million USD | 85.472% |
| Venus Concept Inc. | 52.16 Million USD | -35.423% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -2670.431% |
| Bioventus Inc. | 328.19 Million USD | 78.474% |
| BrainsWay Ltd. | 23.09 Million USD | -205.946% |
| Envoy Medical, Inc. | -473 Thousand USD | 15035.729% |
| electroCore, Inc. | 13.22 Million USD | -434.145% |
| IceCure Medical Ltd | 1.3 Million USD | -5334.308% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 1267.702% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 149343.705% |
| MaxCyte, Inc. | 36.54 Million USD | -93.307% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -15374.999% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -82954.315% |
| PAVmed Inc | -3.96 Million USD | 1880.393% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 1387.985% |
| RxSight, Inc. | 53.76 Million USD | -31.398% |
| Sight Sciences, Inc. | 69.17 Million USD | -2.126% |
| SI-BONE, Inc. | 109.42 Million USD | 35.436% |
| TELA Bio, Inc. | 40.11 Million USD | -76.122% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -344.147% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 53.503% |
| LivaNova PLC | 771.25 Million USD | 90.84% |
| 908 Devices Inc. | 25.32 Million USD | -178.991% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 77.226% |
| Nemaura Medical Inc. | -1.47 Million USD | 4885.044% |
| NeuroPace, Inc. | 48.12 Million USD | -46.806% |
| LENSAR, Inc. | 21.1 Million USD | -234.704% |
| Apyx Medical Corporation | 14.12 Million USD | -400.255% |
| Cutera, Inc. | 41.49 Million USD | -70.256% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -282.677% |
| BioSig Technologies, Inc. | 18 Thousand USD | -392377.778% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 31.47% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -418.922% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 92.048% |
| Axonics, Inc. | 274.55 Million USD | 74.269% |
| Outset Medical, Inc. | 29 Million USD | -143.607% |
| IRIDEX Corporation | 21.8 Million USD | -223.96% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 0.567% |
| IRadimed Corporation | 50.15 Million USD | -40.846% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -24515.331% |
| INVO Bioscience, Inc. | 1.08 Million USD | -6404.33% |
| Telesis Bio, Inc. | 16.95 Million USD | -316.791% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 37.361% |
| Varex Imaging Corporation | 256.9 Million USD | 72.501% |
| Quipt Home Medical Corp. | 163.84 Million USD | 56.882% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 17500.493% |
| Pulmonx Corporation | 50.75 Million USD | -39.198% |
| Dynatronics Corporation | 7.63 Million USD | -825.294% |
| Modular Medical, Inc. | -768 Thousand USD | 9298.698% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -1173.36% |
| Semler Scientific, Inc. | 61.2 Million USD | -15.435% |
| InMode Ltd. | 411.34 Million USD | 82.825% |
| Bruker Corporation | 1.51 Billion USD | 95.342% |
| Cytosorbents Corporation | 22.39 Million USD | -215.496% |
| DexCom, Inc. | 2.28 Billion USD | 96.914% |
| Align Technology, Inc. | 2.71 Billion USD | 97.401% |
| Viveve Medical, Inc. | 620 Thousand USD | -11294.516% |
| ZimVie Inc. | 290.38 Million USD | 75.671% |
| Movano Inc. | -158 Thousand USD | 44812.658% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 35.439% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -82954.315% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 80.787% |
| Profound Medical Corp. | 4.51 Million USD | -1465.035% |
| Insulet Corporation | 1.15 Billion USD | 93.909% |
| enVVeno Medical Corporation | -546 Thousand USD | 13038.828% |
| Surmodics, Inc. | 93.05 Million USD | 24.079% |
| iCAD, Inc. | 14.53 Million USD | -386.007% |
| Nuwellis, Inc. | 4.98 Million USD | -1317.74% |
| Biotricity, Inc. | 8.35 Million USD | -745.424% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 78.709% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 19775.428% |
| InspireMD, Inc. | 1.8 Million USD | -3809.574% |
| PAVmed Inc. | -3.96 Million USD | 1880.393% |
| BIOLASE, Inc. | 16.72 Million USD | -322.423% |
| Beyond Air, Inc. | -1.3 Million USD | 5505.203% |
| FONAR Corporation | 45.14 Million USD | -56.504% |
| AxoGen, Inc. | 127.87 Million USD | 44.753% |
| Vivani Medical, Inc. | -357 Thousand USD | 19888.796% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 63.796% |
| Inari Medical, Inc. | 434.56 Million USD | 83.743% |
| UFP Technologies, Inc. | 112.22 Million USD | 37.05% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -564210.248% |
| Tenon Medical, Inc. | 1.24 Million USD | -5592.667% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 87317.284% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -2589.136% |
| AdaptHealth Corp. | 479.56 Million USD | 85.269% |
| Sintx Technologies, Inc. | 1.84 Million USD | -3733.207% |
| NanoVibronix, Inc. | 1.53 Million USD | -4496.357% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 17500.493% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -402.461% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -33.85% |
| TransMedics Group, Inc. | 154.09 Million USD | 54.154% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -1486.481% |
| NeuroMetrix, Inc. | 3.94 Million USD | -1689.678% |
| Hyperfine, Inc. | 4.75 Million USD | -1385.096% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 33.962% |
| Biomerica, Inc. | 611 Thousand USD | -11462.357% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -69.466% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 9146.104% |
| Silk Road Medical, Inc | 127.08 Million USD | 44.411% |